The best indicator for Insulet Corporation (PODD)
We backtested 20 indicators across daily, weekly and hourly charts on real Insulet Corporation (PODD) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Williams %R
On the weekly chart, this is the strongest risk-adjusted edge we found for Insulet Corporation (PODD) over ~19.1 years — beating buy-and-hold by 0.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Williams %R ✓ | Weekly | 13.1% | 0.55 | -77.7% | 82.6% | 23 | 0.2% |
| 2 | EMA-10 Trend | Weekly | 10.9% | 0.49 | -47.6% | 51.2% | 80 | -1.9% |
| 3 | RSI Trend (>50) ✓ | Weekly | 10.1% | 0.47 | -51.4% | 42.6% | 47 | -2.7% |
| 4 | SMA 50/200 Cross ✓ | Daily | 14.3% | 0.57 | -74.6% | 50.0% | 12 | 1.7% |
| 5 | MACD ✓ | Daily | 10.0% | 0.45 | -68.8% | 50.0% | 178 | -2.6% |
| 6 | EMA 20/50 Cross ✓ | Daily | 9.2% | 0.43 | -56.1% | 37.8% | 45 | -3.4% |
| 7 | Donchian Midline ✓ | Daily | 9.3% | 0.43 | -50.3% | 42.4% | 245 | -3.3% |
| 8 | Stochastic | Weekly | 9.1% | 0.43 | -77.7% | 73.7% | 19 | -3.7% |
| 9 | EMA 50/200 Cross ✓ | Daily | 11.9% | 0.51 | -73.8% | 41.7% | 12 | -0.8% |
| 10 | Donchian Breakout | Daily | 7.7% | 0.4 | -52.3% | 44.6% | 74 | -4.9% |
| 11 | Rate of Change ✓ | Daily | 8.1% | 0.4 | -47.7% | 39.9% | 311 | -4.5% |
| 12 | CCI ✓ | Weekly | 6.2% | 0.35 | -85.2% | 83.3% | 18 | -6.7% |
| 13 | EMA-10 Trend | Daily | 5.9% | 0.34 | -60.5% | 38.8% | 443 | -6.7% |
| 14 | Heikin-Ashi Trend | Weekly | 5.9% | 0.34 | -58.3% | 55.4% | 168 | -7.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Insulet Corporation (PODD), Williams %R on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.